Cap Colour Is Not a Specification: Rebuilding Peptide Identity Checks in the Laboratory SOP

Walk into almost any working lab and you will find the shorthand: the blue-capped vial, the grey one, the one with the yellow ring. It is quick, it is memorable, and it is a genuinely poor basis for identification. When a laboratory standard operating procedure is being revised, cap colour is one of the first visual shortcuts that should be removed and replaced with recordable, verifiable fields. This matters most where small lyophilised vials are handled in volume, and where a misidentified vial can invalidate weeks of in-vitro work.

Why packaging colour drifts into SOPs — and why it cannot carry identity

A vial closure is chosen for mechanical compatibility with the crimping or sealing process, for compatibility with the fill-finish line, for supplier availability, and sometimes for simple product differentiation. It is not selected to encode molecular identity, synthesis route, purity or manufacturing origin. Research Sciences states this directly in its published FAQ material: vial cap colours and other packaging may vary, and cap colour is not an indicator of identity, analytical quality or manufacturing origin. That is the position the supplier puts in writing, and it is the position a laboratory SOP should reflect.

So why does colour end up in documentation at all? Mostly because it is effortless. Bench staff under time pressure reach for the fastest distinguishing feature, and a verbal shorthand becomes a written one. Within a few months, a spreadsheet column, a freezer map or a training note quietly references cap colour as though it were a controlled attribute. The failure modes then accumulate in predictable ways.

First, the same catalogue item arrives in a different colour between deliveries. Packaging changes on a restock are routine, and the supplier’s own FAQ notes that restocked products may carry the same Internal Test Reference (ITR) as earlier stock — an ITR links to associated sample testing reports but does not confirm that separate deliveries come from the same production lot or have received separate independent testing. A colour-based SOP turns a cosmetic change into a spurious deviation investigation.

Second, two different compounds may share a cap colour. With small vials, similar fill volumes and compact labels, colour is the least reliable and most seductive differentiator on the bench. Add condensation from a 2–8 °C short-term storage position, low bench lighting, or the ordinary variation in colour perception between individuals, and the margin for error widens further.

Third, appearance-based assumptions extend beyond the cap. Research Sciences’ FAQ notes that its peptides contain trace amounts of mannitol as an excipient, partly so the vial does not look empty after lyophilisation. A small, tidy-looking pellet and a thin film across the base can be the same product. Neither the cap nor the cake tells a researcher anything about identity or purity. Only documentation does.

Building a defensible identity chain: label references, ITRs and CoAs

Start with the label reference, not the lid

Research Sciences vial labels use a reference format that combines the SKU code with an expiry date, for example BPC10-03/27, and that reference links to the corresponding certificate of analysis. That reference is the correct anchor for a receipt inspection step. In practice, the SOP should require the receiving officer to check the label reference against the purchase order, file the matching CoA, record the date received and the storage location, and note the physical condition of the vial and closure. Cap colour, if recorded at all, belongs in a free-text observations field explicitly marked as cosmetic and non-discretionary.

Treat the CoA as the identity document

The published FAQs state that every compound includes a CoA covering HPLC purity and identity, and the About page describes a full-spectrum testing framework that includes heavy metals and endotoxin evaluation of submitted samples. The homepage lists CoAs referencing Janoshik Analytical Reports. The practical instruction is simple: open the CoA that accompanies the specific batch, read it, and file it against the label reference. Purity headlines such as “≥99% Verified Purity” or “Over 99.1% Purity” are marketing lines on a changing live page; the exact purity figure for a given vial is the one stated on that batch’s CoA and should be reconfirmed there, not inferred from a homepage banner or a cap.

Write a packaging-variability clause

The SOP should say, in plain language, that closure colour, closure style and secondary packaging may change without notice, that such changes are not grounds for rejection on their own, and that an acceptance decision rests on the label reference matching the CoA and the order record. Conversely, a missing CoA, a label reference that does not match the order, or a damaged closure is a documentation or integrity event and should trigger a query. Where the shop needs to be contacted about documentation, quoting the label reference is the fastest route. Laboratories sourcing Uk peptides can apply the same test to any supplier: can every vial be traced to a specific batch document, yes or no?

Practical SOP redlines for the bench and the stores

Remove colour words; add recordable fields

The editing work is unglamorous but specific. Delete colour descriptors from the SOP text, bench sheets, internal requisitions, freezer maps and stock spreadsheets. Replace them with fields that can be audited: catalogue SKU, label reference, CoA file location, date received, storage location, quantity. Where a photograph is taken for a deviation record, caption it by reference, not by appearance. Then revisit training: a competent handler should be able to take an unlabelled-by-colour vial, read the reference, and retrieve the corresponding CoA within a set time. That is the skill worth assessing, and colour matching is not.

Align handling, storage and training with the documentation

Appearance-led habits often travel alongside storage shortcuts. The published handling guidance is worth restating in the SOP: allow vials to reach room temperature before opening, work in a clean environment, remove only the amount required for the experiment, and store lyophilised material at −20 °C or below, sealed with desiccant and protected from moisture, heat and light. Avoid repeated freeze–thaw cycles; reconstituted material is less stable and should be held at 2–8 °C for short-term laboratory use. Reconstitution volumes and concentrations belong strictly inside an in-vitro assay workflow; the free reconstitution calculator is described as a laboratory research tool only and must not be used for human or veterinary dosing. Where a preparation step is needed, materials should be allowed to reach ambient temperature first, as the product listings describe for a research setting.

Materials managers should also tighten procurement language. Reordering by SKU and reference, rather than by description, prevents the drift that starts the problem. Restock notices and packaging differences should be handled through a change-control note rather than a non-conformance, and any change in documentation should be escalated. Fulfilment expectations can be stated as published — next-working-day dispatch, Royal Mail Tracked 24 with tracking issued after dispatch, delivery times as estimates that may vary in peak periods — and reconfirmed at checkout rather than hard-coded into an SOP. Above all, the compliance framing must stay visible on the bench: products are supplied strictly for controlled laboratory and analytical research, labelled “For Research Use Only – Not for Human Consumption”, and are not for human or veterinary use, nor for therapeutic, clinical or diagnostic application. The purchaser remains responsible for lawful use, safe handling, storage, disposal and COSHH compliance. A revised SOP that replaces cap colour with a label reference and a batch CoA removes a routine source of error and leaves an audit trail that stands up to scrutiny.